The global Needle-free Injection Systems market size was valued at US$ 195.7 million in 2023. With growing demand in downstream market, the Needle-free Injection Systems is forecast to a readjusted size of US$ 280.7 million by 2030 with a CAGR of 5.3% during review period.
The research report highlights the growth potential of the global Needle-free Injection Systems market. Needle-free Injection Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Needle-free Injection Systems. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Needle-free Injection Systems market.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 56%.
Key Features:
The report on Needle-free Injection Systems market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Needle-free Injection Systems market. It may include historical data, market segmentation by Power (e.g., Reusable Injector, Single-use Injector), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Needle-free Injection Systems market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Needle-free Injection Systems market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Needle-free Injection Systems industry. This include advancements in Needle-free Injection Systems technology, Needle-free Injection Systems new entrants, Needle-free Injection Systems new investment, and other innovations that are shaping the future of Needle-free Injection Systems.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Needle-free Injection Systems market. It includes factors influencing customer ' purchasing decisions, preferences for Needle-free Injection Systems product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Needle-free Injection Systems market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Needle-free Injection Systems market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Needle-free Injection Systems market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Needle-free Injection Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Needle-free Injection Systems market.
麻豆原创 Segmentation:
Needle-free Injection Systems market is split by Power and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Power, and by Application in terms of volume and value.
Segmentation by power
Reusable Injector
Single-use Injector
Segmentation by application
Vaccine Delivery
Insulin Delivery
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D'Antonio Consultants International
Lepu Medical
TECHiJET
Key Questions Addressed in this Report
What is the 10-year outlook for the global Needle-free Injection Systems market?
What factors are driving Needle-free Injection Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Needle-free Injection Systems market opportunities vary by end market size?
How does Needle-free Injection Systems break out power, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Needle-free Injection Systems Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Needle-free Injection Systems by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Needle-free Injection Systems by Country/Region, 2019, 2023 & 2030
2.2 Needle-free Injection Systems Segment by Power
2.2.1 Reusable Injector
2.2.2 Single-use Injector
2.3 Needle-free Injection Systems Sales by Power
2.3.1 Global Needle-free Injection Systems Sales 麻豆原创 Share by Power (2019-2024)
2.3.2 Global Needle-free Injection Systems Revenue and 麻豆原创 Share by Power (2019-2024)
2.3.3 Global Needle-free Injection Systems Sale Price by Power (2019-2024)
2.4 Needle-free Injection Systems Segment by Application
2.4.1 Vaccine Delivery
2.4.2 Insulin Delivery
2.4.3 Others
2.5 Needle-free Injection Systems Sales by Application
2.5.1 Global Needle-free Injection Systems Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Needle-free Injection Systems Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Needle-free Injection Systems Sale Price by Application (2019-2024)
3 Global Needle-free Injection Systems by Company
3.1 Global Needle-free Injection Systems Breakdown Data by Company
3.1.1 Global Needle-free Injection Systems Annual Sales by Company (2019-2024)
3.1.2 Global Needle-free Injection Systems Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Needle-free Injection Systems Annual Revenue by Company (2019-2024)
3.2.1 Global Needle-free Injection Systems Revenue by Company (2019-2024)
3.2.2 Global Needle-free Injection Systems Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Needle-free Injection Systems Sale Price by Company
3.4 Key Manufacturers Needle-free Injection Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Needle-free Injection Systems Product Location Distribution
3.4.2 Players Needle-free Injection Systems Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Needle-free Injection Systems by Geographic Region
4.1 World Historic Needle-free Injection Systems 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Needle-free Injection Systems Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Needle-free Injection Systems Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Needle-free Injection Systems 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Needle-free Injection Systems Annual Sales by Country/Region (2019-2024)
4.2.2 Global Needle-free Injection Systems Annual Revenue by Country/Region (2019-2024)
4.3 Americas Needle-free Injection Systems Sales Growth
4.4 APAC Needle-free Injection Systems Sales Growth
4.5 Europe Needle-free Injection Systems Sales Growth
4.6 Middle East & Africa Needle-free Injection Systems Sales Growth
5 Americas
5.1 Americas Needle-free Injection Systems Sales by Country
5.1.1 Americas Needle-free Injection Systems Sales by Country (2019-2024)
5.1.2 Americas Needle-free Injection Systems Revenue by Country (2019-2024)
5.2 Americas Needle-free Injection Systems Sales by Power
5.3 Americas Needle-free Injection Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle-free Injection Systems Sales by Region
6.1.1 APAC Needle-free Injection Systems Sales by Region (2019-2024)
6.1.2 APAC Needle-free Injection Systems Revenue by Region (2019-2024)
6.2 APAC Needle-free Injection Systems Sales by Power
6.3 APAC Needle-free Injection Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Needle-free Injection Systems by Country
7.1.1 Europe Needle-free Injection Systems Sales by Country (2019-2024)
7.1.2 Europe Needle-free Injection Systems Revenue by Country (2019-2024)
7.2 Europe Needle-free Injection Systems Sales by Power
7.3 Europe Needle-free Injection Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Needle-free Injection Systems by Country
8.1.1 Middle East & Africa Needle-free Injection Systems Sales by Country (2019-2024)
8.1.2 Middle East & Africa Needle-free Injection Systems Revenue by Country (2019-2024)
8.2 Middle East & Africa Needle-free Injection Systems Sales by Power
8.3 Middle East & Africa Needle-free Injection Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Needle-free Injection Systems
10.3 Manufacturing Process Analysis of Needle-free Injection Systems
10.4 Industry Chain Structure of Needle-free Injection Systems
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Needle-free Injection Systems Distributors
11.3 Needle-free Injection Systems Customer
12 World Forecast Review for Needle-free Injection Systems by Geographic Region
12.1 Global Needle-free Injection Systems 麻豆原创 Size Forecast by Region
12.1.1 Global Needle-free Injection Systems Forecast by Region (2025-2030)
12.1.2 Global Needle-free Injection Systems Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Needle-free Injection Systems Forecast by Power
12.7 Global Needle-free Injection Systems Forecast by Application
13 Key Players Analysis
13.1 Antares Pharma
13.1.1 Antares Pharma Company Information
13.1.2 Antares Pharma Needle-free Injection Systems Product Portfolios and Specifications
13.1.3 Antares Pharma Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Antares Pharma Main Business Overview
13.1.5 Antares Pharma Latest Developments
13.2 Endo International plc
13.2.1 Endo International plc Company Information
13.2.2 Endo International plc Needle-free Injection Systems Product Portfolios and Specifications
13.2.3 Endo International plc Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Endo International plc Main Business Overview
13.2.5 Endo International plc Latest Developments
13.3 Inovio Pharmaceuticals
13.3.1 Inovio Pharmaceuticals Company Information
13.3.2 Inovio Pharmaceuticals Needle-free Injection Systems Product Portfolios and Specifications
13.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Inovio Pharmaceuticals Main Business Overview
13.3.5 Inovio Pharmaceuticals Latest Developments
13.4 Injex Pharma
13.4.1 Injex Pharma Company Information
13.4.2 Injex Pharma Needle-free Injection Systems Product Portfolios and Specifications
13.4.3 Injex Pharma Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Injex Pharma Main Business Overview
13.4.5 Injex Pharma Latest Developments
13.5 National Medical Products Inc (J-Tip)
13.5.1 National Medical Products Inc (J-Tip) Company Information
13.5.2 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Portfolios and Specifications
13.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 National Medical Products Inc (J-Tip) Main Business Overview
13.5.5 National Medical Products Inc (J-Tip) Latest Developments
13.6 Recipharm
13.6.1 Recipharm Company Information
13.6.2 Recipharm Needle-free Injection Systems Product Portfolios and Specifications
13.6.3 Recipharm Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Recipharm Main Business Overview
13.6.5 Recipharm Latest Developments
13.7 European Pharma Group (InsuJet)
13.7.1 European Pharma Group (InsuJet) Company Information
13.7.2 European Pharma Group (InsuJet) Needle-free Injection Systems Product Portfolios and Specifications
13.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 European Pharma Group (InsuJet) Main Business Overview
13.7.5 European Pharma Group (InsuJet) Latest Developments
13.8 Miracle Medical
13.8.1 Miracle Medical Company Information
13.8.2 Miracle Medical Needle-free Injection Systems Product Portfolios and Specifications
13.8.3 Miracle Medical Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Miracle Medical Main Business Overview
13.8.5 Miracle Medical Latest Developments
13.9 Medical International Technology (MIT)
13.9.1 Medical International Technology (MIT) Company Information
13.9.2 Medical International Technology (MIT) Needle-free Injection Systems Product Portfolios and Specifications
13.9.3 Medical International Technology (MIT) Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Medical International Technology (MIT) Main Business Overview
13.9.5 Medical International Technology (MIT) Latest Developments
13.10 Akra Dermojet
13.10.1 Akra Dermojet Company Information
13.10.2 Akra Dermojet Needle-free Injection Systems Product Portfolios and Specifications
13.10.3 Akra Dermojet Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Akra Dermojet Main Business Overview
13.10.5 Akra Dermojet Latest Developments
13.11 PharmaJet
13.11.1 PharmaJet Company Information
13.11.2 PharmaJet Needle-free Injection Systems Product Portfolios and Specifications
13.11.3 PharmaJet Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 PharmaJet Main Business Overview
13.11.5 PharmaJet Latest Developments
13.12 Portal Instruments
13.12.1 Portal Instruments Company Information
13.12.2 Portal Instruments Needle-free Injection Systems Product Portfolios and Specifications
13.12.3 Portal Instruments Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Portal Instruments Main Business Overview
13.12.5 Portal Instruments Latest Developments
13.13 Crossject Medical Technology
13.13.1 Crossject Medical Technology Company Information
13.13.2 Crossject Medical Technology Needle-free Injection Systems Product Portfolios and Specifications
13.13.3 Crossject Medical Technology Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Crossject Medical Technology Main Business Overview
13.13.5 Crossject Medical Technology Latest Developments
13.14 MIKA MEDICAL
13.14.1 MIKA MEDICAL Company Information
13.14.2 MIKA MEDICAL Needle-free Injection Systems Product Portfolios and Specifications
13.14.3 MIKA MEDICAL Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 MIKA MEDICAL Main Business Overview
13.14.5 MIKA MEDICAL Latest Developments
13.15 Ferring Pharmaceuticals
13.15.1 Ferring Pharmaceuticals Company Information
13.15.2 Ferring Pharmaceuticals Needle-free Injection Systems Product Portfolios and Specifications
13.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Ferring Pharmaceuticals Main Business Overview
13.15.5 Ferring Pharmaceuticals Latest Developments
13.16 D'Antonio Consultants International
13.16.1 D'Antonio Consultants International Company Information
13.16.2 D'Antonio Consultants International Needle-free Injection Systems Product Portfolios and Specifications
13.16.3 D'Antonio Consultants International Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 D'Antonio Consultants International Main Business Overview
13.16.5 D'Antonio Consultants International Latest Developments
13.17 Lepu Medical
13.17.1 Lepu Medical Company Information
13.17.2 Lepu Medical Needle-free Injection Systems Product Portfolios and Specifications
13.17.3 Lepu Medical Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Lepu Medical Main Business Overview
13.17.5 Lepu Medical Latest Developments
13.18 TECHiJET
13.18.1 TECHiJET Company Information
13.18.2 TECHiJET Needle-free Injection Systems Product Portfolios and Specifications
13.18.3 TECHiJET Needle-free Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 TECHiJET Main Business Overview
13.18.5 TECHiJET Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
